W. Jonat

16.5k citations
313 papers · 10.3k · 3 hit papers · h-index 51

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Bone health and treatments
    • Cancer Risks and Factors

Papers in

    • Breast Cancer Treatment Studies 64
    • Protease and Inhibitor Mechanisms 12
    • Estrogen and related hormone effects 68

W. Jonat

284 papers receiving 9.8k citations

W. Jonat's Hit Papers

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer 2009 · 517 citations
5170+7+14Years since publication200400600

Peers

W. Jonat
Comparison fields: 5 of 153
  • Cancer Research 3.1k
  • Oncology 3.8k
  • Genetics 3.0k
  • Reproductive Medicine 818
  • Obstetrics and Gynecology 556
Replace Christian F. Singer with:
Christian F. Singer Austria
Christian Marth Austria
Lynn C. Hartmann United States
R. Kreienberg Germany
Joachim Diebold Germany
Peggy L. Porter United States
Patrice Watson United States
Ossama Tawfik United States
Emilio Bajetta Italy
Marion Kiechle Germany
W. Jonat relative to Christian F. Singer Austria Christian F. Singer's profile →
Citations per field
00.5×1.5×2×2.4×
Christian F. Singer · 1×
Citations per year

Countries citing papers authored by W. Jonat

Since Specialization
Citations

This map shows the geographic impact of W. Jonat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Jonat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Jonat more than expected).

Fields of papers citing papers by W. Jonat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Jonat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Jonat. The network helps show where W. Jonat may publish in the future.

Co-authors

The 25 scholars most cited alongside W. Jonat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W. Jonat Line = papers co-authored together W. Jonat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 313 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Hit paper breakdown →
2005680
2
Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
Hit paper breakdown →
2006570
3
Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
Hit paper breakdown →
2009517
4 2007358
5
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.
1998355
6 1996322
7 2002259
8 1996220
9 2007206
10 2003203
11 1993189
12 2006165
13 2004162
14 1998148
15 2015147
16
Expression of the tumor suppressor gene Maspin in human pancreatic cancers.
2001146
17 1998142
18 1998139
19 2005135
20 2013124

About W. Jonat

W. Jonat is a scholar working on Cancer Research, Genetics, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 313 papers that have together received 10.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (68 papers), Breast Cancer Treatment Studies (64 papers), Cancer Treatment and Pharmacology (30 papers), HER2/EGFR in Cancer Research (26 papers), Advanced Breast Cancer Therapies (18 papers), Ovarian cancer diagnosis and treatment (17 papers), Prenatal Screening and Diagnostics (14 papers) and Protease and Inhibitor Mechanisms (12 papers). The work is most often cited by research in Cancer Research (3.1k citations), Oncology (3.8k citations), Genetics (3.0k citations), Reproductive Medicine (818 citations) and Obstetrics and Gynecology (556 citations). W. Jonat has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include W. Eiermann, Manfred Kaufmann, Christoph Mundhenke, Anthony Howell, Nicolaì Maass, Michael Gnant, Carl Blomqvist, Gϋnter von Minckwitz, Liselotte Mettler and İbrahim Alkatout. Their work appears in journals such as Journal of Clinical Oncology, Archives of Gynecology and Obstetrics, European Journal of Cancer, Journal of Cancer Research and Clinical Oncology and Fertility and Sterility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact